Intellectual Property Regime Improves

Two recent developments have encouraged BMI to upgrade China's score for 'Intellectual property' from six to seven on our Pharmaceuticals Business Environment Ratings. This makes the country marginally more attractive to multinational drugmakers looking to launch innovative

To read the full article, please choose one of the following options: